Is WideOpenWest, Inc. overvalued or undervalued?
As of February 23, 2023, WideOpenWest, Inc. is considered overvalued and risky due to poor financial metrics, including a Price to Book Value of 2.02 and a ROE of -30.26%, alongside a year-to-date stock performance of -16.73%, contrasting with the S&P 500's 2.44% return.
As of 23 February 2023, the valuation grade for WideOpenWest, Inc. has moved from very expensive to risky, indicating a shift in perception regarding its financial health and market position. The company is currently considered overvalued based on its financial metrics. Key ratios include a Price to Book Value of 2.02, an EV to EBITDA of 5.69, and a ROE of -30.26%, reflecting significant operational challenges.In comparison to its peers, WideOpenWest, Inc. shows a less favorable position; for instance, Lumen Technologies, Inc. has a P/E of -8.05 and an EV to EBITDA of 5.85, while IDT Corp. stands out with an attractive P/E of 18.33 and an EV to EBITDA of 12.45. The company's recent stock performance has been poor, with a year-to-date return of -16.73%, contrasting sharply with the S&P 500's 2.44% return, further underscoring the concerns regarding its valuation.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
